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In the period 1971-81, more than 1.9 million persons were registered with a malignant
neoplasm among the 49.2 million population of England and Wales. For 63,536 people, two or
more tumor registrations (multiple tumor records) have arisen in that period. Because of the
structure ofthe National Cancer Registration scheme, some errors in registration are inevitable,
particularly duplicate registration ofa single tumor by adjacent regional cancer registries. A pilot
study showed that 61 percent of multiple records would represent true multiple primary
malignancy, and that these records could be readily separated from registration errors.
After abstraction of identifying codes from each tumor, 129,047 tumors involved in 63,536
multiple records were matched to the national cancer file, and the full data set extracted for
successfully matched tumors. Person-years data were extracted for the 1.8 million tumors not
involved in a multiple record. Eleven percent of multiple records were not completely matched,
and a further 16 percent were excluded on SEER criteria, or as probable registration errors,
leaving 46,155 multiple primary tumors for further analysis. Over 3 million person-years at riskof
a second tumor wereaccrued. Theoverall riskofa second tumor at anysitebefore age 85 was0.77
for males and 0.80 for females, after exclusion ofsecond tumors observed within 12 months ofthe
first. The riskofa new primary apparently decreased with increasing duration ofsurvival, a trend
which may be due in part to under-registration of second tumors in the early 1970s and an
improvement in linkage since 1971.
INTRODUCTION
The study of multiple primary malignant neoplasms may provide information
relevant both to the etiology and to the management of cancer [1]. In discussing the
incidence of bilateral breast tumors, Prior and Waterhouse [2] comment that
"knowledge ofabsolute and differential rates ofsecond primary tumours is not only of
great clinical importance for the future management of the breast cancer patient, but
might give some clues to the aetiology of the disease itself'; their remark has a wider
relevance for second malignancies in general.
Two malignant tumors arising in one individual may share a common genetic
predisposition, as with retinoblastoma, or a common environmental etiology, as with
bladder and respiratory tract tumors associated with the use oftobacco. Studying the
association of two or more tumors in multiple primary neoplasia may therefore offer
new clues to the etiology of cancer. The management of patients with one tumor may
also be improved ifthose at highest risk ofa second tumor can be identified from such
studies, leading to appropriate surveillance and earlier, more effective treatment for
the second tumor. The therapy for a first tumor has itself been recognized as an
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important cause ofsecond primary neoplasms [3,4]: study of multiple primary tumors
may be expected both to improve the choice of therapy for a first tumor and to identify
the most probable site or type of a second primary for the purposes of surveillance.
The occurrence oftwo or more primary neoplasms in one individual may also be the
result of chance. Study of this condition therefore requires access to a large body of
data, because only a small proportion (perhaps 1 in 20) of patients with one
malignancy will be expected to develop a second. In attempting to derive unbiased
estimates of the incidence of second tumors, the individuals studied should be an
unbiased sample-preferably a complete (100 percent) sample-of the population
with a first tumor. A series of patients treated at a large hospital specializing in cancer
therapy is unlikely to be representative of cancer patients as a whole, whether for site or
stage of disease, or for other prognostic factors, unless the hospital treats all cancer
patients in its territory.
Population-based data on the incidence of second malignancies remain scanty.
Schoenberg [5] has provided evidence from the Connecticut Tumor Registry that
patients with one cancer have 1.29 times the risk of developing a new primary cancer
compared with individuals who never had cancer, studying over 5,000 second tumors
registered in 30 years (1935-64) among 121,000 cancer patients. The risk was 1.37 for
females and 1.20 for males. A study of 5,300 second cancers observed among 180,000
women treated for cervix cancer and registered at one of 15 population-based regional
or national registries has been reported [6]. Recently Teppo et al. [7] reported 5,000
second cancers among nearly 280,000 cancer patients registered in the Finnish Cancer
Registry from 1953-79. They noted an inverse relation between second tumor risk and
age at first cancer, and the risk in females (1.09) was higher than for males (0.89), but
their overall risk (0.99) did not confirm the overall result from the Connecticut
Registry.
In England and Wales, fourteen' population-based regional cancer registries have
covered the entire population since 1962 (Fig. 1). The Office of Population Censuses
and Surveys (OPCS) collates registration data from all these registries to produce
national incidence figures: about 200,000 tumors are registered annually. Each
registry aims to record all new primary malignancies arising in residents of its territory
and can usually link the records of two or more cancers in the same individual. Until
recently, population-based studies of multiple primary malignancy in England and
Wales would have been feasible only within regional registries; Prior and Waterhouse
have published several such studies from the West Midlands registry [2,8-10]. But the
population available to any one regional registry is relatively small; not all registries
have computerized records or separate files for multiple cancer; record linkage
efficiency varies among registries; and people who migrate across registry boundaries
in the interval between their first and second cancer would not be detected as having
multiple cancer.
From 1971, however, the National Cancer Registration scheme was modified, in
order to obtain automatic survival data, by linking all new cancer registrations and
death certifications on a single alphabetic index, the National Health Service Central
Register (NHSCR) at Southport. There was an unexpected by-product of the new
scheme. If, instead ofdeath, the next vital event in a cancer patient was another cancer
registration, the system now produced a multiple tumor record, evidence of multiple
'The three Thames registries amalgamated on
1 January 1985; there are now only 12 registries.
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FIG. 1. Cancer regis-
tries in England and Wales;
the three Thames registries
amalgamated in 1985.
cancer (Fig. 2). Multiple records were returned to OPCS and stored. This change
accidentally removed most of the problems of studying multiple cancer in regional
registries. Linkage efficiency was high and largely independent of the cancer registry
concerned; multiple cancer in migrants would be detected; and, above all, the entire
national population was covered. But the scheme was not designed to detect multiple
cancer, and errors ofregistration, particularly duplicate registration ofa single tumor,
either within one registry or between two registries, also gave rise to multiple tumor
records. This report describes an attempt to exploit the National Cancer Registration
scheme ofEngland and Wales to study multiple primary cancer.
POPULATION AND METHODS
Regional cancer registries receive tumor notifications from hospitals and general
practitioners, and copies of death certificates mentioning cancer for residents of their
territory. Each registry maintains an alphabetic index, which serves both to avoid
duplicate registration ofa single tumor and to link two tumors in one person. However,
a patient treated in two centers either side of a registry boundary will occasionally be
registered in both registries.
The 1981 census population of England and Wales was 49.244 million. In the 11
years 1971-81, more than 1.9 million tumors among this population were flagged2 at
The National Health Service Central Register (NHSCR), excluding those registered
at death or in non-residents. During this period, 63,536 multiple tumor records have
2Flagging an individual at NHSCR ensures automatic notification of death (1939- ) and of any cancer
registration (1971- ).
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arisen (by October 1984 the figure exceeded 00,000). A multiple tumor record is
defined in this context as two or more tumor registrations linked at NHSCR to the
same individual, each registered between January 1971 and 31 December 1981.
A random percent sample of multiple records for the decade 1971-80 was
examined in detail, with the registry or registries involved. This pilot study showed that
86 percent of multiple records involving a single registry represented multiple primary
malignant neoplasms, while the corresponding figure for those involving two or more
registries was only 8 percent (Table 1). Duplicate registrations of a single tumor
accounted for most of the remainder, but a third of the duplicates involving only a
single registry had been detected and cancelled by the registry concerned. Faulty
registration of metastases from a previously registered tumor accounted for 2 percent
of the multiple records. No instance was found of linkage error, i.e., two tumors in
different persons wrongly linked to one person's record.
TABLE I
Results of 1 Percent Sample Study: Multiple Record Category by
Registry Involvement
All One Two
Records Registry Registries
Number of records 398a 283 115
Percentage classified as:
Multiple primary 64 86 8
Duplicate 34 11 89
Metastases 2 2 3
Linkage error 0 0 0
Other 1 1 1
'Excludes 50 records; 32 from N-E Thames registry, which suspended operation
during the pilot study, and 18 for which all but one tumor registration had already
been detected as an error and cancelled by the registry concerned. At the time of
survey, only the estimated number (44,800) of multiple records for 1971-80 was
available, hence sample size of 448.
Cancer
deaths
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This pilot survey showed that at least 64 percent ofall the multiple records could be
expected to be multiple primary neoplasms, and that most registration errors could be
removed using criteria applicable within a computer program.
Four key identifiers (year of registration, code identifying the registry, tumor serial
number within that registry, and anniversary date ofthe tumor) were abstracted from
each tumor registration in each multiple record and entered into a computer file. A
new multiple tumor number was automatically assigned to each tumor, consisting ofa
serial number from 1 to N, with a terminal digit representing the ordinal rank (1st,
2nd, 3rd, and so on) of each tumor within each multiple record. The resulting file,
containing 63,536 multiple tumor records involving 129,047 registrations, was then
sorted into the same sequence as the national cancer file and matched against it (Fig.
3). Three files resulted. Where all four identifiers on a tumor from a multiple record
matched perfectly with a tumor on the national file, all the data on that tumor were
extracted. Tumors from the multiple file for which a perfect match could not be found
were stored separately. For tumors on the national file not involved in a multiple
record, sufficient data were extracted to derive the person-years3 at risk of a second
tumor. Individuals were censored on reaching their hundredth birthday, if this
preceded death, emigration, or the end ofthe study period on 31 December 1981.
Multiple records for which all component tumor registrations were successfully
matched to an extant registration on the national cancer file were submitted to two
further sets of checks. First, they were searched for probable errors of registration or
linkage, using criteria derived from the pilot study. For example, multiple records
involving two regional registries were excluded (unless they had previously been edited
at OPCS to remove duplicates) because the pilot study had shown that only 8 percent
3Person-years: the sum of the (variable) number of years for which each person was followed up, i.e.,
observed whilst at risk of a second tumor. More appropriate than just the number of persons for use as the
denominator of (second cancer) incidence rates, since some are observed only briefly, others for many
years.
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were likely to represent multiple primary malignancy. Next, the records were checked
with an algorithm designed to apply the Surveillance, Epidemiology and End Results
program (SEER) criteria for multiple primary malignancy [ 1]. For this purpose, site
was defined at the three-digit level of the eighth revision of the International
Classification of Diseases (ICD) [12], after conversion [13] of ninth revision codes
[14] for 1979-81. Records in which one or both of the tumors had been assigned a
non-specific site-code (195-9) were excluded. For colon, rectum, bone, connective
tissue and skin, site was defined at the four-digit level. Histology was defined at the
three-digit level. A simplified schema ofthe algorithm used to apply these checks and
exclusions is given in Fig. 4.
Expected numbers of second tumors were calculated by multiplying the age, sex,
and calendar year-specific incidence rate for the second cancer site of interest by the
person-years accrued by individuals with the first cancer within the same categories of
age, sex, and time, then summing across all age groups and calendar years. Expected
numbers are then compared with theobserved number ofsecond tumors. The result is a
set of relative risks (observed/expected) for a particular second tumor among those
with a given first tumor, for each sex and for each combination of two tumor sites,
adjusted for age, calendar time, and survival from the first tumor. Such results can be
examined separately for various time periods since each subject's first tumor (the
interval at risk of a second tumor) to see if second cancer risk changes as survival
increases.
The assumption underlying such calculations is that the risk of a tumor does not
change appreciably within the age strata used; five-year age intervals are sufficiently
small for this purpose for most tumors, but infants under oneyearofage areconsidered
separately. Under the null hypothesis that the two tumors are rare independent events,
the number of observed tumors can be treated as a random variable drawn from a
Poisson distribution with mean equal to the expected number. The significance ofany
excess ofobserved tumors is assessed accordingly.
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TABLE 2
Editing of Multiple Tumor Records
Original data 63,536
Not matched 1,092
Partially matched 5,766
Acceptable sequences 56,678
Sex error 207
Two registries 5,291
Ill-defined site 1,983
Duplicates 2,988
Metastases 54
Multiple primary tumors 46,155
RESULTS
For 1,092 of the 63,536 original multiple records, neither of the tumors in the pair
could be matched (Table 2), either because the tumor registration(s) had been
previously cancelled or because of keying errors in preparation of the multiple file.
These records will be reviewed in due course but are not considered further here. For a
further 5,766 multiple records, one or more tumor registrations was successfully
matched and extracted, but at least one was not. These records contain defective
sequences of tumors (1-3; 2-3, and so on) and are also excluded from further
consideration here.
A total of 56,678 multiple tumor records were fully matched to extant registrations
on the national cancer file. These were further edited using the algorithm (Fig. 4).
Different sex codes were found within 207 multiple records: these were excluded as
possible linkage errors (Table 2). Records involving two or more registries were also
excluded (see Methods). About 400 (8 percent) true multiple primaries may have been
rejected among the 5,291 records in this category: they will be retrieved for analysis
after further checks have been carried out. Almost 2,000 records involving a first or
second tumor site-coded to 195-9 (ill-defined or secondary neoplasms) were excluded.
Nearly 3,000 further records were rejected on the basis ofSEER criteria involving site,
histology, and time, and a further 54 because one ofthe first two tumors was coded as
metastatic.
After removal of 10,523 records in this way, 46,155 multiple tumor records were
considered acceptable for further analysis as multiple primary malignancies. These
records contained two or more tumors satisfying the SEER definition of multiple
primary malignancy, summarized in Table 3.
The distribution of first and second tumors by year ofoccurrence is shown in Table
4. The largest number of second tumors occurs in the same year as the first, with a
gradual decline in successive years. More than a third ofall second tumors arise in the
same calendar year as the first, but this is largely a function of the relatively short
follow-up (11 years at most), and theproportion falls to one-sixth where up to ten years
of follow-up are available. This pattern appears more clearly in Table 5, where the
number of second tumors arising with a given delay since the first tumor is seen to be
fairly stable, regardless ofthe calendar year in which the first tumor was registered.
The distributions of first and second tumors in a multiple primary by broad
site-group and by individual site are given in Tables 6 and 7, respectively. First tumors
in a given site-group or site may be linked with second tumors at any site, and vice
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TABLE 3
Criteria for Multiple Primary Malignancy
1. Neither tumor has non-specific site code (195-9).
2. Tumors are at different sites
and either have different histology
or same histology and
neither is metastatic
OR
Tumors are at same site
and either have different histology
or same histology and
neither is metastatic and
they are more than 60 days apart.
versa: thus over 7,700 tumors of the digestive tract were observed as first tumors in a
multiple primary followed by a second tumor at any site, while more than 11,000
tumors of the digestive tract occurred as second tumors, preceded by a first tumor at
any site. These tables show that considerable numbers ofmultiple tumors are available
for study at most sites: for example, more than 1,100 second leukemias.
Person-years at risk of a second tumor were accrued by almost 1.9 million
individuals: their distribution by sex and by time since diagnosis of the first tumor is
given in Table 8. Excluding the first twelve months since diagnosis, more than 2.75
million person-years were observed, almost three-quarters (73 percent) ofthese before
the fifth anniversary of diagnosis of the first tumor. Only 16,000 person-years were
accrued beyond the tenth anniversary: all these would be in subjects whose first tumor
was diagnosed in 1971 and survived until some time in 1981 or beyond. At this stage,
therefore, the available information on second cancer risk beyond ten years of
follow-up will be scanty.
Results for second malignant tumors at any site (ICD-8 140-209) following a first
malignant tumor at any site are presented in Table 9, for males and females up to the
age of 84. Simultaneous tumors are excluded from this table (2,717 and 2,371 for
males and females, respectively). A total of 11,159 second tumors were observed in
males at least 12 months after the first tumor, against 14,424.5 expected, an overall
risk of 0.77. Among females, there were 9,538 observed against 11,883.6 expected
second tumors between one and 11 years after the first tumor, an overall risk of 0.80.
For both sexes, the second tumor riskexceeded unity in the twelve months immediately
after diagnosis ofthe first tumor and was less than unity thereafter. For each sex, there
is a downward trend of second cancer risk with time. Each individual risk estimate is
significantly different from unity (p < 0.01) and each time trend is also significant
(p < 0.001).
DISCUSSION
Review ofa 1 percent random sample ofan estimated 44,800 multiple tumor records
arising in England and Wales during the period 1971-1980 had shown that 64 percent
could be expected to represent multiple primary malignancy; the proportion would be
much higher (86 percent) among multiple records for which all the tumors originated
from a single registry. The review also showed that more than 100,000 such records
had arisen by the end of 1984, and that it would be feasible to separate registration
errors from multiple primary cancers [15].
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TABLE 6
Multiple Tumors by Site-Group
First Second
1CD-8 Site-Group Tumors Tumors
150-8 Digestive 7,728 11,129
160-2 Respiratory 4,789 8,843
170-2 Bone, soft, skin 847 729
180-4 Female genital 3,424 3,256
200-2 Lymphomas 976 1,121
204-7 Leukemias 1,012 1,187
140-239 All sites 46,155 46,155
TABLE 7
Multiple Tumors by Site
First Second
ICD-8 Site Tumors Tumors
140 Lip 285 124
141 Tongue 211 177
142 Salivary gland 173 136
143 Gum 83 60
144 Floor ofmouth 110 92
145 Mouth, NOS 143 115
146 Oropharynx 141 123
147 Nasopharynx 47 54
148 Hypopharynx 113 125
149 Pharynx, NOS 50 53
150 Esophagus 468 963
151 Stomach 1,210 2,556
152 Small intestine 107 132
153 Colon 3,064 3,602
154 Rectum 2,206 2,219
155 Liver 124 217
156 Gall bladder 127 244
157 Pancreas 355 1,112
158 Peritoneum 67 84
159 Digestive, NOS 22 51
160 Nose, sinuses 149 121
161 Larynx 819 480
162 Trachea, bronchus 3,821 8,242
163 Respiratory, NOS 73 101
170 Bone 74 103
171 Connective, soft tissue 252 224
172 Melanoma 521 402
173 Other skin 10,843 5,659
174 Breast (M and F) 5,499 4,237
180 Cervix 952 685
181 Chorionepithelioma 4 10
182 Uterus, other 1,254 1,020
183 Ovary 939 1,223
184 Other female genital 275 318
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TABLE 7-continued
First Second
ICD-8 Site Tumors Tumors
185 Prostate 2,081 2,365
186 Testis 92 71
187 Other male genital 125 82
188 Bladder 3,157 2,588
189 Other urinary 760 939
190 Eye 118 83
191 Brain 205 336
192 Other CNS 77 63
193 Thyroid 168 171
194 Other endocrine 55 61
200 Lymphosarcoma 391 445
201 Hodgkin's disease 252 187
202 Other lymphoid 333 489
203 Myeloma 306 383
204 Lymphatic leukemia 699 585
205 Myeloid leukemia 215 440
206 Monocytic leukemia 18 41
207 Other leukemia 80 121
208 Polycythemia vera 187 61
209 Myelofibrosis 88 40
- Benign, in situ, etc. 2,167 1,540
140-209 Total malignant 43,988 44,615
140-239 All registrations 46,155 46,155
Data were extracted from national cancer files for more than 56,000 complete
sequences oftumors, ofwhich 46,155 appear to be multipleprimary malignancies. The
distribution of these tumors by site and by time is consistent with what would be
expected for multiple primary malignancies. To be included in the data, both the first
and the second tumor had toberegistered in the 11-year interval 1971-81. During that
period there was a steady decline in the annual number of first tumors involved in a
multiple primary by 1981 (Fig. 5). There was a parallel increase in the annual number
ofsecond tumors, as the total population at riskofa second tumor since 1971 gradually
increased (Table 4).
The pattern of occurrence by year and by period at risk (Tables 4 and 5) suggests
TABLE 8
Person-Years at Risk (1971-81) by Sex and Time Since First Tumor
Years Since Diagnosis of First Tumor
Category 0- 1-4 5-9 10-11 Totala
Male 510,004.8 805,173.9 269,910.7 5,947.2 1,081,031.8
Female 617,638.5 1,212,625.9 449,995.1 10,090.8 1,672,711.8
Total 1,127,643.3 2,017,799.8 719,905.8 16,038.0 2,753,743.6
'Excluding first year offollow-up.
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TABLE 9
Second Malignant Tumors (Any Site), Following a First Malignant Tumor (Any Site), England and
Wales, 1971-81: Males and Females Aged 0-84
Years Since Diagnosis ofFirst Tumor
0- 1-4 5-9 10-11 Totala
Males
Person-years
(thousands) 480.0 743.8 245.9 5.4 995.2
Observed 7,876 8,487 2,632 40 11,159
Expected 6,818.7 10,660.6 3,677.9 86.0 14,424.5
Relative risk 1.16 0.80 0.72 0.47 0.77
Females
Person-years
(thousands) 555.9 1,063.0 380.0 8.3 1,451.2
Observed 6,217 7,176 2,327 35 9,538
Expected 4,420.0 8,575.2 3,235.8 72.6 11,883.6
Relative risk 1.41 0.84 0.72 0.48 0.80
aExcluding the first year offollow-up. Totals may not sum exactly because ofrounding.
that about 4,600 multiple primaries were being recorded each year by 1981, and that
this figure will increase by perhaps 200 a year for several more years. It would be
expected to stabilize only when all prevalent cases ofcancer have been diagnosed since
1971.
The multiple tumor data studied hereoriginated as a spin-offfrom the acquisition of
passive survival data by flagging ofcancer patients at NHSCR. As such, the linkage of
two tumors to one individual has been carried out without thedetailed checks made by
many individual registries with an interest in multiple primary malignancy. Whilst this
carries disadvantages, such as the need to exclude administrative errors ofregistration,
there is at least one compensation. It may be an advantage to hold multiple records
which would be considered as multiple primary malignancy by some criteria, but not
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by others. The data do not depend on the past application ofcriteria which might now
be considered inappropriate. New or alternative sets of criteria can be applied to the
entire data set in order to demonstrate any differences in recorded incidence which
their application would be likely to produce. Equally, but on a more parochial note,
systematic examination of the errors of registration detected in this study will be
expected to lead to improvements in the National Cancer Registration scheme.
Since flagging only began in 1971, any second cancers arising since then in
individuals with a previous, unflagged cancer registered before 1971 will not have been
linked to the prior tumor. The proportion ofsecond cancers undetected for this reason
will be expected to decay steadily, reaching zero when all surviving cancer patients
have been registered since 1971, and flagged. For many cancers, survival beyond 10 or
12 years is still uncommon, and the OPCS multiple records may already be expected to
contain virtually all second cancers that have been registered.
The overall risk of a second tumor is not raised, a result which is consistent with
those recently reported from Finland [7] and Denmark [Storm et al., this issue], but at
odds with results from Connecticut [Boice et al, this issue]. The downward trend of
second cancer risk with time since diagnosis of the first tumor was unexpected and is
opposite to the trends reported from all three registries mentioned above, although
none of the trends is large. Possible explanations include under-registration of second
cancer, particularly for patients diagnosed in the early 1970s when there may have
been less awareness of multiple tumors, and less readiness to attach a new tumor
diagnosis to the patient's record for ultimate abstraction by registry staff. The Danish
study cited above has suggested that under-registration there may have resulted in up
to 20 percent reduction in observed second-cancer risk. It is also possible that efficiency
of linkage between two tumors at NHSCR has improved since flagging of tumor
registrations began in 1971. Up to 14 percent ofmultiple primaries may also have been
excluded from the data by the automatic editing processes described here. Inclusion of
these records will require additional checks on the accuracy of the data. Finally,
mortality data for cases registered in 1971 and 1972 is now known to have been
complete only up to October 1981: the use of 31 December 1981 as the end of study
date for these subjects will have resulted in overestimation ofperson-years at risk, and
a corresponding reduction in risk (O/E) at 10+ and 9+ years, respectively.
Further analysis will now be done to explore links between specific pairs ofprimary
sites, after refinement of the criteria used to distinguish multiple primaries from
duplicate registrations. The OPCS data on multiple primary malignant neoplasms
should be particularly valuable for the study of more recently introduced therapeutic
regimes for a first primary cancer, because the large volume ofdata will enable precise
risk estimation, to compensate in part for the relatively short duration offollow-up.
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